Empowerment and Support for the Diabetic Patient
CHANGE-D
Coaching for Health to Achieve New Goals in Empowerment for Diabetes
1 other identifier
interventional
300
0 countries
N/A
Brief Summary
CHANGE-D objectives are to evaluate to what extent personal coaching for healthy lifestyle and treatment adherence improves clinical outcomes among uncontrolled diabetic patients. Evaluate to what extent personal coaching for healthy lifestyle and treatment adherence improves self treatment among uncontrolled diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 25, 2014
CompletedFirst Posted
Study publicly available on registry
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedAugust 6, 2015
August 1, 2015
2 years
June 25, 2014
August 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical composite
Change from baseline in a composite endpoint of HbA1c, BMI, Blood Pressure, Lipids at 6, 12 and 18 months from randomization
0, 6, 12, 18 months from randomization
Secondary Outcomes (2)
Change in Self Treatment Score
0, 6, 12, 18 months from randomization
Change in Self Efficacy Score
0, 6, 12, 18 months from randomization
Other Outcomes (1)
Change in Quality of life score
0, 12 months from randomization
Study Arms (2)
Health coaching
EXPERIMENTALPatients receive health coaching via the phone, face to face or group support, according to patients' choice
Standard of Care
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Type 2 diabetes
- At least one oral anti diabetic drug
- HbA1c above 7.5% ot above 0.5% of personal target
- Preparedness for change
- Fluent Hebrew or Arabic
You may not qualify if:
- Type 1 diabetes
- Pregnancy or lactation
- Incompetency to sign consent
- Participation in another clinical trial
- Unstable psychotic disease
- Complex health condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clalit Health Serviceslead
- Merck Sharp & Dohme LLCcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department Manager of Quality Promotion, Community Medical Division
Study Record Dates
First Submitted
June 25, 2014
First Posted
July 1, 2014
Study Start
June 1, 2014
Primary Completion
June 1, 2016
Last Updated
August 6, 2015
Record last verified: 2015-08